TELCOR POC Device Connectivity Updates - Q4 2025
Lincoln, NE – February 17, 2026
The FDA had until May 30 to appeal U.S. District Court Judge Sean D. Jordan's decision to vacate the agency's Final Rule seeking to regulate laboratory developed tests (LDTs). The federal government declined to appeal the judge's decision meaning the Texas District Court's decision to vacate, in its entirety, the FDA's attempt to regulate LDTs as medical devices stands.
Read ACLA’s full lawsuit.
Read the Final Judgment.
Lincoln, NE – February 17, 2026
Company Recognized for Ongoing Commitment to Culture, Performance, and Innovation Lincoln, Nebraska – February 16,2026 – TELCOR Inc is proud to...
President Donald Trump signed the Consolidated Appropriations Act of 2026 (H.R.7148) into law on Feb. 3, delaying Medicare Clinical Laboratory Fee...